Groupe Berkem (the 'Group'), a leading player in bio-based chemicals (ISIN code: FR00140069V2 - Ticker: ALKEM) (Paris:ALKEM), announces its 2023 financial calendar.
ABOUT GROUPE BERKEM
Founded in 1993 by Olivier Fahy, Chairman and Chief Executive Officer, Groupe Berkem is a leading force in the bio-based chemicals market. Its mission is to advance the environmental transition of companies producing the chemicals used in everyday lives (cosmetics, food and beverages, construction, public hygiene, etc.). By harnessing its expertise in both plant extraction and innovative formulations, Groupe Berkem has developed bio-based boosters-unique high-quality bio-based solutions augmenting the performance of synthetic molecules. Groupe Berkem achieved revenue of EUR46 million and an EBITDA margin close to 20% in 2021. The Group has almost 170 employees working at its head office (Blanquefort, Gironde) and three production facilities in Gardonne (Dordogne), La Teste-de-Buch (Gironde), and Chartres (Eure-et-Loir).
Groupe Berkem has been listed on Euronext Growth Paris since December 2021 (ISIN: FR00140069V2 - ALKEM).
Contact:
Groupe Berkem
Olivier Fahy
Chief Executive Officer
Anthony Labrugnas
Chief Financial Officer
Tel: +33 (0)5 64 31 06 60
E: investisseurs@berkem.com
NewCap
Investor
Mathilde Bohin
Nicolas Fossiez
Tel: +33 (0)1 44 71 94 94
E: Berkem@newcap.eu
NewCap
Media
Nicolas Merigeau
Antoine Pacquier
Tel: +33 (0)1 44 71 94 94
E: Berkem@newcap.eu
(C) 2022 Electronic News Publishing, source ENP Newswire